Ignite Creation Date:
2025-12-25 @ 3:52 AM
Ignite Modification Date:
2026-03-25 @ 5:30 AM
Study NCT ID:
NCT05965102
Status:
UNKNOWN
Last Update Posted:
2023-07-28
First Post:
2023-04-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tirellizumab Combined With Chemotherapy Monotherapy for Non-small Cell Lung Cancer
Sponsor:
Second Affiliated Hospital of Guangzhou Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2022-LCYJ-ZF-10
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None